肱骨外上髁炎治疗市场规模、份额、成长分析(按治疗类型、最终用户和地区)- 产业预测(2025 年至 2032 年)
市场调查报告书
商品编码
1789241

肱骨外上髁炎治疗市场规模、份额、成长分析(按治疗类型、最终用户和地区)- 产业预测(2025 年至 2032 年)

Lateral Epicondylitis Treatment Market Size, Share, and Growth Analysis, By Treatment Type (Non-Surgical Treatments, Surgical Treatments), By End User (Hospitals, Specialty Clinics), By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 172 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球肱骨外上髁炎治疗市场预计在 2023 年价值 12 亿美元,从 2024 年的 12.5 亿美元增长到 2032 年的 17.4 亿美元,预计在预测期内(2025-2032 年)的复合年增长率为 4.2%。

由于患有重复性劳损的人数不断增加,尤其是运动员、体力劳动者和上班族,全球肱骨外上髁炎治疗市场正在经历显着增长。 PRP注射和衝击波疗法等微创治疗方案的日益普及,以及预防措施意识的不断增强,正在扩大治疗的可及性。此外,再生医学的进步,加上门诊手术中心的激增,正在扩大患者的治疗选择。老年人口的不断增长以及对早期疗育重要性的日益重视,进一步促进了市场的扩张,为全球肱骨外上髁炎治疗方案创造了一个强劲的环境。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二次资料和一次资料方法
  • 市场规模预测
  • 市场假设与约束

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分机会分析

市场动态与展望

  • 市场概览
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特的分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数(2024年)
  • PESTEL分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 案例研究
  • 顾客购买行为分析

肱骨外上髁炎治疗市场规模:依治疗类型及复合年增长率(2025-2032)

  • 市场概览
  • 非手术治疗
    • 製药
    • 物理治疗
    • 正畸和牙套
    • 其他非手术治疗
  • 手术治疗
    • 关节镜手术
    • 开放性手术
    • 其他外科治疗

肱骨外上髁炎治疗市场规模:依年龄层及复合年增长率(2025-2032)

  • 市场概览
  • 孩子们
  • 成人
  • 老年人

肱骨外上髁炎治疗市场规模:依最终用户和复合年增长率(2025-2032)

  • 市场概览
  • 医院
  • 专科诊所
  • 门诊手术中心
  • 居家照护环境

肱骨外上髁炎治疗市场规模:按地区及复合年增长率(2025-2032)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业市场定位(2024年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市场占有率分析(2024年)
  • 主要企业简介
    • 公司详情
    • 产品系列分析
    • 按部门分類的公司份额分析
    • 收益同比对比(2022-2024 年)

主要企业简介

  • Teikoku Pharma, Inc.
  • Kasiak Research Pvt. Ltd.
  • Molecular Pharmacology Limited
  • Chugai Pharmaceutical Co., Ltd.
  • Seikagaku Corporation
  • OMRON Corporation
  • BioMedical Life Systems, Inc.
  • Zynex, Inc.
  • EMS Physio Ltd.
  • DJO Global, Inc.
  • Beurer GmbH
  • 3M
  • AKSIGEN
  • BTL Corporate

结论和建议

简介目录
Product Code: SQMIG45N2126

Global Lateral Epicondylitis Treatment Market size was valued at USD 1.2 billion in 2023 and is poised to grow from USD 1.25 billion in 2024 to USD 1.74 billion by 2032, growing at a CAGR of 4.2% during the forecast period (2025-2032).

The global market for lateral epicondylitis treatment is experiencing significant growth driven by a rise in individuals affected by repetitive strain injuries, particularly among athletes, manual laborers, and office workers. The increasing availability of minimally invasive treatment options, such as PRP injections and shockwave therapy, along with heightened awareness of preventive measures, is enhancing treatment accessibility. Furthermore, advancements in regenerative medicine, coupled with the proliferation of ambulatory surgical centers, are broadening the options available for patients. The expanding elderly population and an increasing recognition of the importance of early intervention further contribute to the market's expansion, creating a robust landscape for lateral epicondylitis treatment solutions worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lateral Epicondylitis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lateral Epicondylitis Treatment Market Segments Analysis

Global Lateral Epicondylitis Treatment Market is segmented by Treatment Type, End User and region. Based on Treatment Type, the market is segmented into Non-Surgical Treatments and Surgical Treatments. Based on End User, the market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgical Centres and Homecare Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lateral Epicondylitis Treatment Market

The rising prevalence of lateral epicondylitis among various groups, including athletes, manual laborers, and office employees, significantly fuels the demand in the treatment market. This surge is largely attributed to the rise in repetitive motion activities across different occupations. Consequently, there is a heightened need for both non-surgical treatments, such as braces and physiotherapy, as well as surgical options like arthroscopic release. This trend is particularly pronounced in developed areas with aging populations who actively seek effective solutions for managing this condition. Overall, the broader awareness and recognition of lateral epicondylitis drive the market's growth trajectory.

Restraints in the Global Lateral Epicondylitis Treatment Market

Despite the efficacy of biologic treatments such as platelet-rich plasma and stem cell therapies, as well as shockwave therapy, their high costs combined with inconsistent insurance coverage-particularly in less developed regions-pose significant challenges. This financial hurdle restricts their widespread use and encourages healthcare providers and patients to turn to more affordable non-biologic options, such as corticosteroids. As a result, the market for Lateral Epicondylitis treatment is impacted, with a tendency to favor less expensive alternatives that may not offer the same long-term benefits, thus hindering the adoption of advanced therapeutic methods.

Market Trends of the Global Lateral Epicondylitis Treatment Market

The Global Lateral Epicondylitis Treatment market is witnessing a significant shift toward regenerative medicine, particularly with the increasing adoption of biologic therapies such as platelet-rich plasma therapy, stem cell injections, and growth factor-based treatments. These innovative therapies are gaining traction due to their potential to enhance natural tissue repair and reduce recurrence rates, appealing to both healthcare providers and patients seeking effective long-term solutions. This trend is especially pronounced in North America and Europe, where healthcare systems are increasingly supportive of these advanced treatment modalities, indicating a broader acceptance of biologics within traditional healthcare frameworks and driving market growth.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Customer Buying Behavior Analysis

Global Lateral Epicondylitis Treatment Market Size by Treatment Type & CAGR (2025-2032)

  • Market Overview
  • Non-Surgical Treatments
    • Medications
    • Physical therapy
    • Orthotics and braces
    • Other non-surgical treatments
  • Surgical Treatments
    • Arthroscopic surgery
    • Open surgery
    • Other surgical treatments

Global Lateral Epicondylitis Treatment Market Size by Age Group & CAGR (2025-2032)

  • Market Overview
  • Pediatric
  • Adult
  • Geriatric

Global Lateral Epicondylitis Treatment Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centres
  • Homecare Settings

Global Lateral Epicondylitis Treatment Market Size & CAGR (2025-2032)

  • North America (Treatment Type, Age Group, End User)
    • US
    • Canada
  • Europe (Treatment Type, Age Group, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Treatment Type, Age Group, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Treatment Type, Age Group, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Treatment Type, Age Group, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Teikoku Pharma, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kasiak Research Pvt. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molecular Pharmacology Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Chugai Pharmaceutical Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Seikagaku Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OMRON Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioMedical Life Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zynex, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EMS Physio Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DJO Global, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beurer GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3M
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AKSIGEN
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BTL Corporate
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations